What are the causes of hemolytic anemia in elderly patients?

Causes of Hemolytic Anemia in Elderly Patients

In elderly patients, hemolytic anemia most commonly results from autoimmune processes, drug-induced mechanisms, underlying malignancies (particularly lymphoproliferative disorders), and nutritional deficiencies—with autoimmune hemolytic anemia and drug-induced hemolysis being the predominant causes requiring immediate diagnostic consideration. 1, 2

Primary Causes by Category

Autoimmune Hemolytic Anemia (AIHA)

• Warm AIHA accounts for 60-70% of autoimmune cases, mediated by IgG autoantibodies reacting at body temperature 3
• Cold agglutinin disease (CAD) represents 20-25% of cases, caused by IgM autoantibodies reacting below 20°C with strong complement activation 3
• Approximately 50% of warm AIHA cases are primary (idiopathic), while the remainder are secondary to underlying conditions 3
• The elderly show increased autoimmune phenomena even without overt disease due to age-related immune system changes 2

Drug-Induced Hemolysis

• Checkpoint inhibitors can cause hemolytic anemia through autoantibody development, typically managed by withholding the drug, corticosteroids, and IVIG 1
• Ceftriaxone has been documented to cause subacute hemolytic anemia in geriatric patients, often requiring multiple transfusions before diagnosis 4
• Common culprits include ribavirin, rifampin, dapsone, interferon, cephalosporins, penicillins, NSAIDs, quinine/quinidine, fludarabine, ciprofloxacin, and diclofenac 1
• Phenazopyridine (urinary analgesic) can cause hemolysis, particularly in elderly patients with renal insufficiency 5

Malignancy-Associated Hemolysis

• Chronic lymphocytic leukemia commonly presents with autoimmune hemolytic anemia 6
• Waldenström macroglobulinemia causes cold agglutinin-mediated chronic hemolytic anemia in fewer than 10% of patients, with cold agglutinin titers typically exceeding 1:1,000 7
• Lymphoproliferative disorders are a major secondary cause of AIHA in the elderly 3
• Histiocytic tumors can cause erythrophagocytosis leading to hemolysis 6
• Myeloproliferative neoplasms may cause hypersplenism with sequestration and destruction of red cells 6

Microangiopathic Processes

• Thrombotic microangiopathy (TMA) can present with hemolytic features including schistocytes, elevated LDH, and low haptoglobin 8
• Disseminated intravascular coagulation should be evaluated in the differential diagnosis 9, 10
• Cancer-related microangiopathic processes occur in various malignancies 6

Nutritional Deficiencies

• Vitamin B12 deficiency can present with TMA-like hemolytic features including macrocytic anemia, schistocytes, high LDH, hyperbilirubinemia, and low haptoglobin 11
• Type A gastritis with hypergastrinemia, high homocysteine, and anti-intrinsic factor/anti-parietal cell antibodies are common findings 11
• Post-gastrectomy status predisposes to B12 deficiency-related hemolysis 11
• Hemolysis typically resolves within 4 weeks of B12 replacement therapy 11

Hereditary Causes (May Present Late)

• Pyruvate kinase deficiency can be misdiagnosed as acquired pure red cell aplasia or myelodysplastic syndrome when presenting in the sixth decade of life 12, 9
• Red cell morphology is usually unremarkable with some anisocytosis and poikilocytosis, making diagnosis challenging 9
• Reticulocytosis is not proportional to hemolysis severity due to splenic sequestration of younger cells 9

Critical Diagnostic Approach

Initial Laboratory Evaluation

When anemia plus thrombocytopenia presents, immediately determine haptoglobin, indirect bilirubin, and LDH levels 8

Classic hemolysis markers include:

• Increased reticulocyte count, elevated LDH, reduced haptoglobin, elevated unconjugated bilirubin 9, 10
• Direct antiglobulin test (DAT/Coombs) to distinguish immune (DAT-positive) from non-immune (DAT-negative) causes 10

Comprehensive Workup for Suspected AIHA

• Blood chemistry, CBC with peripheral smear evaluation for schistocytes and macrocytosis 1
• Direct and indirect bilirubin, LDH, direct agglutinin test 1
• Autoimmune serology, protein electrophoresis, cryoglobulin analysis 1
• Paroxysmal nocturnal hemoglobinuria screening 1
• Evaluation for viral/bacterial causes (mycoplasma, parvovirus) 1
• Glucose-6-phosphate dehydrogenase levels 1
• Assessment for methemoglobinemia 1

Essential Exclusions

• Medication review for all drugs known to cause hemolysis 1
• B12, folate, copper, thyroid function to exclude nutritional/metabolic causes 1, 11
• Bone marrow analysis is highly advisable in elderly patients both at diagnosis to detect underlying conditions and during follow-up to monitor for bone marrow failure or neoplastic evolution 2
• If no obvious cause identified, cytogenetic analysis to evaluate for myelodysplastic syndromes 1

Important Clinical Pitfalls

Diagnostic Challenges

• Schistocytes >1% favor TMA diagnosis, but their absence should not exclude early TMA diagnosis due to low test sensitivity 8
• Vitamin B12 deficiency can mimic TMA with identical laboratory features; always check B12 in elderly patients with hemolysis and macrocytosis 11
• Late-onset hereditary conditions like pyruvate kinase deficiency may be misdiagnosed as acquired disorders in elderly patients 12, 9
• Reticulocytopenia may be present despite hemolysis, indicating inadequate bone marrow compensation requiring erythropoietin consideration 3

Complications Requiring Monitoring

• Infections and thrombosis are major complications of AIHA requiring vigilant surveillance 2
• Prophylactic anticoagulation should be considered for severe hemolysis 3
• High-output cardiac failure and thromboembolism can complicate chronic hemolysis 10
• Pigment gallstones occur with increased frequency in chronic hemolytic states 10

Comorbidity Considerations

• Underlying deficiencies, medications, neoplasms, and chronic organ failures frequently challenge differential diagnosis in elderly patients and must be systematically evaluated 2
• Renal insufficiency increases risk of drug-induced hemolysis (e.g., phenazopyridine) 5
• Multiple overlapping causes may coexist in elderly patients requiring comprehensive evaluation 2